Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Expanded adipose-derived mesenchymal stem cells are multipotent stromal/stem cells from fat tissue with robust expansion capability in vitro. They offer multilineage differentiation potential along with strong paracrine-mediated immunomodulatory effects—making them attractive candidates for regenerative medicine applications involving soft-tissue repair or modulation of inflammation/metabolism.
Paracrine signaling via growth factors and cytokines; immunomodulation through cytokine secretion and macrophage polarization; tissue regeneration via angiogenesis and wound healing.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Expanded Adipose-Derived Mesenchymal Stem Cells (eASC).